Mylan offers to buy Swedish pharma firm Meda for $9.9 bn
US pharmaceutical giant Mylan said Wednesday it has struck a $9.9 billon deal to buy Meda, capping two years of dogged pursuit of the Swedish drugmaker.
Feb 11, 2016, 07:29 AM ISTMeda and Cipla sue Apotex to enforce Dymista patents
Sweden-based drug firm Meda Pharmaceuticals Inc and Cipla Ltd have "sued" Apotex Inc and Apotex Corp in Federal District Court in Delaware in US to enforce patents of its allergy drug 'Dymista'.
Dec 03, 2014, 14:52 PM IST